Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma

Emel Altuncu, Su Berrak, Hülya Bilgen, Ziya Yurdakul, Cengiz Canpolat, Eren Özek

Research output: Contribution to journalArticle

6 Scopus citations


Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.

Original languageEnglish (US)
Pages (from-to)627-629
Number of pages3
JournalJournal of Maternal-Fetal and Neonatal Medicine
Issue number8
Publication statusPublished - Aug 13 2007



  • Bleeding diasthesis
  • Factor VIIa
  • Preterm

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this